AMB-05X

· AmMax Bio, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AMB-05X, covering 2024-05-24 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment [Phase 2]